Targeting Anemia with Erythropoietin during Critical Illness
- 6 September 2007
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (10) , 1037-1039
- https://doi.org/10.1056/nejme078150
Abstract
The overall goals of clinical research in the intensive care unit (ICU) are to improve clinical outcomes through enhanced understanding of how critical illness develops and how such illness is best prevented, diagnosed, treated, or palliated. Several “normal” physiological measurements and laboratory values have been abandoned as therapeutic targets during critical illness, since in some randomized trials, attempts to normalize these measurements and values have shown either harm or no benefit with respect to clinical outcomes.Keywords
This publication has 7 references indexed in Scilit:
- Efficacy and Safety of Epoetin Alfa in Critically Ill PatientsNew England Journal of Medicine, 2007
- Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysisThe Lancet, 2007
- Elevated Cardiac Troponin Measurements in Critically Ill PatientsArchives of internal medicine (1960), 2006
- Deep venous thrombosis: clinically silent in the intensive care unitJournal of Critical Care, 2005
- Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factorsCritical Care Medicine, 2005
- Blood conservation in the intensive care unitCritical Care Medicine, 2003
- A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical CareNew England Journal of Medicine, 1999